Share
The Gist Healthcare Podcast
Why Pregnant Women Are Still Missing From Drug Trials and Why It Matters Now
•
For decades, pregnant women have been excluded from most clinical drug trials. The policy was meant to protect mothers and babies, but it has left major gaps in medical knowledge. Now, renewed debate over the safety of common medicines like Tylenol has brought those gaps into sharp focus.
In this episode, STAT News reporter Lizzy Lawrence joins host J. Carlisle Larsen to discuss how history, politics, and caution shaped the science of pregnancy, and what it will take to ensure women are fully included in research that affects their health.
You can read her piece here.
More episodes
View all episodes
Friday, November 14, 2025
08:46|On today’s Gist Healthcare Podcast: The government shutdown ends without an agreement to extend Affordable Care Act tax credits. Canada loses its measles elimination status, signaling renewed public health risks. And the Trump Administration seems likely to extend telehealth flexibilities that allow clinicians to prescribe controlled substances without an in-person visit.Wednesday, November 12, 2025
08:39|On today’s Gist Healthcare Podcast: The Senate passes a spending bill to end the government shutdown without extending Affordable Care Act subsidies. The FDA plans to remove black box warnings from hormone replacement therapies for menopause. And UnitedHealthcare pulls back coverage for remote patient monitoring.Data Reveal Stronger Surgical Outcomes Across US Hospitals
12:26|A new analysis from Vizient and the American Hospital Association shows that outcomes for hospitalized surgical patients have improved in recent years. In this episode, Chris DeRienzo, Senior Vice President and Chief Physician Executive for the AHA, discusses the data behind those findings and what may be contributing to the changes. The conversation looks at how hospitals are managing increasingly complex patients while maintaining gains in safety and quality.Friday, November 7, 2025
06:15|The Trump Administration reaches a deal to lower prices on weight loss drugs, the FDA fast-tracks biosimilars, and a new report shows UnitedHealthcare pays its Optum physicians more than others. Hear the latest on The Gist Healthcare Podcast.Wednesday, November 5, 2025
07:20|On today’s episode of The Gist Healthcare Podcast, CMS finalizes a Medicare pay bump for physicians. Kimberly-Clark to purchase Tylenol maker Kenvue, and Pfizer sues to block Novo Nordisk’s merger with an obesity startup.Friday, October 31, 2025
07:13|Millions of Americans relying on food assistance could lose benefits as the government shutdown continues. A new study explores how proposed H-1B visa changes may affect staffing in rural hospitals. Plus, a court ruling dismisses a case from nurse practitioners challenging the definition of “doctor.” All that and more on today’s episode of The Gist Healthcare Podcast.Wednesday, October 29, 2025
07:41|Texas files suit against the maker of Tylenol, alleging hidden autism risks. Furloughed CMS employees are called back to manage Medicare and ACA enrollment. And Cigna takes a new approach to drug pricing by moving away from rebates. Hear these stories and more on The Gist Healthcare Podcast.Monday October 27, 2025
07:55|In this episode of the Gist Healthcare Podcast, the nation’s second-largest measles outbreak continues to expand along the Arizona–Utah border. Family job-based health insurance premiums hit an average of $27,000 in 2025, while UnitedHealth Group launches an AI tool designed to accelerate medical claims processing.Friday, October 24, 2025
08:46|Moderate House Republicans are urging Speaker Mike Johnson to take up the issue of expiring Affordable Care Act tax credits once the shutdown ends. A new poll shows declining trust in President Trump and Health Secretary Robert F. Kennedy Jr., while DocGo moves to acquire SteadyMD. Those stories and more on The Gist Healthcare Podcast.